Shares of Spectral AI, Inc. (MDAI) are falling about 12 percent in Tuesday morning trading after the company announced that the U.S. Food and Drug Administration granted De Novo Classification for its DeepView System, which is used in burn care in various settings.
The company's stock is currently trading at $2.34, down 12.72 percent, over the previous close of $2.68 on the Nasdaq. It has traded between $1.18 and $3.21 in the past one year.
With this classification, Spectral AI is authorized to commence commercial distribution activities in the United States.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.